NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Nano-X Imaging Ltd. (NNOX) Stock Analysis

Nano-X Imaging Ltd. (NNOX) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

NNOX

$0.38

−$0.03 (−6.87%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NNOX with… →

NNOX Key Statistics

As of Oct 21, 2026
Trading
Open
$0.41
Previous Close
$0.41
Day's Range
0.37–0.42
52-Week Range
0.36–4.71
Volume
886.79K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.26
Valuation
Market Cap
$30.25M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.93
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.72
Financials (FY)
Revenue (FY)
$13.02M+15.40%
Net Income (FY)
−$75.02M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
78.59M
1-Year Return
−90.57%
Dividend and dates
Earnings Date
November 19, 2026estimated
Avg Volume
1.15M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, NNOX closed at $0.38, −90.57% over 1 year.

Nano-X Imaging Ltd. (NNOX) has a market capitalization of $30.25M.

In fiscal 2025, NNOX reported revenue of $13.02M.

NNOX Stock Return by Calendar Year

Nano-X Imaging Ltd. (NNOX) return since Aug 2020: what $10,000 became

1 year
$10,000 $943
−90.57%
5 years
$10,000 $162
−98.38%
Since Aug 2020
$10,000 $177
−98.23%

If you had invested $10,000 in Nano-X Imaging Ltd. (NNOX) at the close on August 21, 2020, the earliest close on record here, it would have been worth $177 at the close on October 21, 2026: −98.23% in total, −48.00% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−86.25%
2025−61.11%
2024+13.03%
2023−13.69%
2022−49.24%
2021−68.16%
2020 (partial year)+110.41%

As of October 21, 2026.

NNOX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$13.02M−$75.02M−576.1%
2024$11.28M−$53.52M−474.3%
2023$9.91M−$60.78M−613.6%
2022$8.58M−$113.24M−1,320.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$13.02M−$12.79M−$60.70M−$75.02M−576.1%
2024$11.28M−$10.61M−$56.75M−$53.52M−474.3%
2023$9.91M−$6.59M−$59.66M−$60.78M−613.6%
2022$8.58M−$6.88M−$87.21M−$113.24M−1,320.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NNOX Valuation vs Medical Devices Median

Median of 145 stocks
MetricNNOXMedical Devices medianvs median
P/S ratio1.932.5324% below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Nano-X Imaging Ltd. (NNOX) is capitalised at $30.25M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 197.

The 52-week range on file runs from $0.36 to $4.71. NNOX last closed at $0.38 on October 21, 2026. That is −$0.03 (−6.87%) against the previous close. The latest close sits 6.92% above that 52-week low.

Financial Health

In fiscal 2025, Nano-X Imaging Ltd. reported revenue of $13.02M. Against the prior fiscal year total of $11.28M, that is a change of +15.40%. The same year closed with a net loss of $75.02M. Earnings per share on a trailing basis come to −1.72.

Across the 4 fiscal years on file, revenue moves from $8.58M in 2022 to $13.02M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 1.93 times revenue. On price-to-sales that is 23.51% below the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Beta against the wider market is reported at 1.26. Daily returns over the trailing 6 years annualize to a volatility of 95.29%. The trailing one-year total return is −90.57%. Measured over 5 years, that is −56.13% a year compounded.

Growth & Income

The record shows no dividend for NNOX.

Across the complete calendar years on file, 2024 returned +13.03% and 2021 returned −68.16%. Of the 5 complete calendar years on file, 1 finished higher. So far in 2026 the total return is −86.25%.

Peer Comparison

Nano-X Imaging Ltd. (NNOX) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Nano-X Imaging Ltd. NNOX $30.25M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Nano-X Imaging Ltd. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Nano-X Imaging Ltd.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Visit website →